Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial

BACKGROUND AND OBJECTIVE: Most guidelines in the UK, Europe and North America do not recommend organised population-wide screening for prostate cancer. Prostate-specific antigen-based screening can reduce prostate cancer-specific mortality, but there are concerns about overdiagnosis, overtreatment a...

Descripción completa

Detalles Bibliográficos
Autores principales: Keeney, Edna, Sanghera, Sabina, Martin, Richard M., Gulati, Roman, Wiklund, Fredrik, Walsh, Eleanor I., Donovan, Jenny L., Hamdy, Freddie, Neal, David E., Lane, J. Athene, Turner, Emma L., Thom, Howard, Clements, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674711/
https://www.ncbi.nlm.nih.gov/pubmed/36201131
http://dx.doi.org/10.1007/s40273-022-01191-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674711/
https://www.ncbi.nlm.nih.gov/pubmed/36201131
http://dx.doi.org/10.1007/s40273-022-01191-1

Ejemplares similares